Globus Medical | GMED - Sales Revenues

Stock Price
90.59
Daily Change
-0.33 -0.36%
Monthly
-3.78%
Yearly
12.84%
Q1 Forecast
87.78

Globus Medical reported $769M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 177.8M 2.8M Sep/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Globus Medical USD 769M 23.7M Sep/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
J&J USD 24.6B 610M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 384.2M 1.7M Sep/2025
Orthofix International USD 799.49M 602.88M Dec/2024
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025